Schram, A. M., Gbolahan, O. B., Neuzillet, C., Arnold, D., Hollebecque, A., Greil, R., Hallak, M. N. A., Ahnert, J. R., Reiss, K. A., Porte, P. L., Guren, T. K., Ragsdale, C. E., Garner, F., Ricart, A. D., Adeyemi, S., Springfeld, C. (2026). Continued zenocutuzumab treatment beyond progression in patients with
                    <i>NRG1+</i>
                    pancreatic cancer and cholangiocarcinoma: Analysis from the phase 2 eNRGy trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.703